A detailed history of Transcendent Capital Group LLC transactions in Viatris Inc stock. As of the latest transaction made, Transcendent Capital Group LLC holds 620 shares of VTRS stock, worth $6,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
620
Previous 620 -0.0%
Holding current value
$6,578
Previous $6.72 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 01, 2024

BUY
$8.77 - $10.85 $5,437 - $6,727
620 New
620 $6.72 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Transcendent Capital Group LLC Portfolio

Follow Transcendent Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcendent Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcendent Capital Group LLC with notifications on news.